FAP and sarcoma: Although sarcomas can have high uptake on FAP PET, it does not appear to improve staging compared to FDG PET, and its role may be limited to sarcomas with low FDG avidity and high FAP expression (e.g. solitary fibrous tumor) and selection for radioligand therapy (RLT) (14).